Clinical Trials Directory

Trials / Completed

CompletedNCT02203188

Effect of Debridement-scaling on the Relief of Dry Eye Signs and Symptoms in Sjogren's Syndrome

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
14 (estimated)
Sponsor
University of Waterloo · Academic / Other
Sex
All
Age
17 Years
Healthy volunteers
Not accepted

Summary

Sjogren's Syndrome is an autoimmune condition in which the body attacks its own glands in the body. Some of these glands are responsible for providing lubrication for the eye. As a result, individuals with Sjogren's Syndrome often experience dry eye. Recently, a study had shown that dry eye symptoms were improved by removing debris and old skin cells along the eyelid margin. This technique is called eyelid debridement-scaling. The purpose of this study is to determine how well this technique works in improving dry eye signs and symptoms in individuals with Sjogren's Syndrome.

Conditions

Interventions

TypeNameDescription
PROCEDURELid debridgement scaling

Timeline

Start date
2014-08-01
Primary completion
2014-11-01
Completion
2014-11-01
First posted
2014-07-29
Last updated
2014-12-19

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT02203188. Inclusion in this directory is not an endorsement.

Effect of Debridement-scaling on the Relief of Dry Eye Signs and Symptoms in Sjogren's Syndrome (NCT02203188) · Clinical Trials Directory